Drug Details
INO-4800 is a DNA vaccine candidate designed to prevent COVID-19 infection.
Study Purpose
This is an open-label trial to evaluate the safety, tolerability and immunological profile of INO-4800 administered by intradermal (ID) injection followed by electroporation (EP) using CELLECTRA® 2000 device in healthy adult volunteers.
